0001609623-14-000002.txt : 20140604 0001609623-14-000002.hdr.sgml : 20140604 20140604095157 ACCESSION NUMBER: 0001609623-14-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20140604 DATE AS OF CHANGE: 20140604 EFFECTIVENESS DATE: 20140604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Remiges BioPharma Fund, LP CENTRAL INDEX KEY: 0001609623 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-218532 FILM NUMBER: 14889502 BUSINESS ADDRESS: STREET 1: 404 UNDERHILL ROAD CITY: SCARSDALE STATE: NY ZIP: 10583 BUSINESS PHONE: (914) 263-2303 MAIL ADDRESS: STREET 1: 404 UNDERHILL ROAD CITY: SCARSDALE STATE: NY ZIP: 10583 D 1 primary_doc.xml X0707 D LIVE 0001609623 Remiges BioPharma Fund, LP 404 UNDERHILL ROAD SCARSDALE NY NEW YORK 10583 (914) 263-2303 CAYMAN ISLANDS None None Limited Partnership true 2014 N/A REMIGES BIOPHARMA FUND GP, INC. 404 UNDERHILL ROAD SCARSDALE NY NEW YORK 10583 Executive Officer GENERAL PARTNER OF THE ISSUER (THE "GENERAL PARTNER") WALTER OLESIAK 404 UNDERHILL ROAD SCARSDALE NY NEW YORK 10583 Executive Officer Director COO, SECRETARY AND DIRECTOR OF THE GENERAL PARTNER TARO INABA 23-16-304 WAKAMATSU-CHO SHINJUKU-KU TOKYO M0 JAPAN 162-0056 Director DIRECTOR AND CHAIRMAN OF THE BOARD OF THE GENERAL PARTNER Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 false true false true false 0 150000000 0 150000000 false 0 0 0 0 THE ISSUER IS OBLIGATED TO PAY A MANAGEMENT FEE TO THE GENERAL PARTNER (OR AN AFFILIATE THEREOF). false Remiges BioPharma Fund, LP /S/WALTER OLESIAK WALTER OLESIAK COO AND SECRETARY OF THE GENERAL PARTNER 2014-06-04